Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

Emergency Use Authorizations

Emergency Use Authorizations (EUA) are a mechanism that allows the U.S. FDA to facilitate the availability of medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats, including emerging infectious diseases such as COVID-19 and pandemic influenza, during public health emergencies. Products that receive emergency health authorizations may be legally marketed and sold in the U.S. for the duration of the emergency or until authorization is revoked by FDA.   

Listen to the full episode on Veristat’s Advancing Revolutionary Therapies (ART) Podcast to learn more about the four primary criteria for an Emergency Use Authorization, navigating the U.S. regulatory environment, and the many nuances key to the success of an Emergency Use Authorization application.

Learning Points

  • Qualifications for the Emergency Use Authorization program
  • How to successfully apply for an Emergency Use Authorization
  • Data requirements for Emergency Use Authorizations
  • Converting Emergency Use Authorizations to full approvals

LISTEN TO PODCAST

Unlocking Insights: The Impact of New Medical Device EU Regulation (MDR)

Unlocking Insights: The Impact of New Medical Device EU Regulation (MDR)

Learn about the impact of the new EU Medical Device Regulation (MDR) on the development of medical devices and drug-device combination products. Gain...

Read More
FDA Guidance Series on Patient-Focused Drug Development (PFDD) to Enhance Product Development and Regulatory Decision Making

FDA Guidance Series on Patient-Focused Drug Development (PFDD) to Enhance Product Development and Regulatory Decision Making

As the industry continues to adopt a patient-centric approach, the use of real-world data is becoming increasingly essential in informing drug...

Read More
Exploring Future Trends on European Regulations: A Webinar by Veristat and TOPRA

Exploring Future Trends on European Regulations: A Webinar by Veristat and TOPRA

Stay informed about the future trends in European regulations on medicines with Veristat and TOPRA. Explore the new Pharmaceutical Strategy for...

Read More